GLP-1 RAs in T1DM Show No Increased Severe Hypoglycemia or DKA Tags Diabetic ketoacidosis Hypoglycemia GLP-1 agonists Read more about GLP-1 RAs in T1DM Show No Increased Severe Hypoglycemia or DKA
Longstanding T2DM With Anemia Carries Greater Risk for Diabetic Retinopathy Tags Diabetic Nephropathy Retinopathy Read more about Longstanding T2DM With Anemia Carries Greater Risk for Diabetic Retinopathy
AACE 2026: Tirzepatide Improves Quality of Life Than Dulaglutide in T2DM-ASCVD Tags Coronary artery disease GLP-1 agonists Read more about AACE 2026: Tirzepatide Improves Quality of Life Than Dulaglutide in T2DM-ASCVD
LOPS Signals Higher Burden of Diabetic Foot Complications Over Time Tags Diabetic foot. Read more about LOPS Signals Higher Burden of Diabetic Foot Complications Over Time
AACE 2026: Empagliflozin Shows Lower PE and DVT Risk vs Dapagliflozin Tags SGLT-2 Inhibitor Read more about AACE 2026: Empagliflozin Shows Lower PE and DVT Risk vs Dapagliflozin
Higher HbA1c Threshold May Better Stratify Adult T1DM Risk Tags hBA1c Read more about Higher HbA1c Threshold May Better Stratify Adult T1DM Risk
AACE 2026: Basal-Based Insulin Improves Inpatient Glycemic Control in T2DM Tags Hyperglycemia hyperosmolar state Long acting Read more about AACE 2026: Basal-Based Insulin Improves Inpatient Glycemic Control in T2DM
AACE 26: Synthetic Semaglutide Delivers Similar HbA1c, Weight Outcomes in T2DM Tags GLP-1 agonists PLBS hBA1c Read more about AACE 26: Synthetic Semaglutide Delivers Similar HbA1c, Weight Outcomes in T2DM
Brolucizumab Improves BCVA Compared With PRP in PDR Tags Retinopathy Read more about Brolucizumab Improves BCVA Compared With PRP in PDR
T Cell Immunotherapy Preserves β-Cell Function in New-Onset T1DM Read more about T Cell Immunotherapy Preserves β-Cell Function in New-Onset T1DM